KOC
CELL

Koss-Olinger Consulting’s PhenomeX Inc. Common Stock CELL Stock Holding History

Koss-Olinger Consulting’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,000
Closed -$986K – 280
2021
Q2 		$986K Buy
22,000
+4,000
+22% +$185K 0.15% 86
2021
Q1 		$904K Buy
+18,000
New +$1.23M 0.15% 83

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Koss-Olinger Consulting's CELL Position: Q3 2021 in Review

Koss-Olinger Consulting sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 22,000 shares — an estimated $986K sold.

Koss-Olinger Consulting first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $986K in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Koss-Olinger Consulting reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Koss-Olinger Consulting sold 22,000 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $986K.
  • Koss-Olinger Consulting first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Koss-Olinger Consulting's PhenomeX Inc. Common Stock position peaked at $986K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Koss-Olinger Consulting's 13F filing for Q3 2021, filed 9 Nov 2021.